Adolescents

Children and adolescents using an advanced hybrid closed-loop system for type 1 diabetes can tolerate an unannounced snack containing 20 g of carbohydrate without excessive blood sugar fluctuations, Italian researchers report.

The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial.

A nationwide population-based study reveals a link between obesity in adolescence and an increased risk for type 1 diabetes in young adulthood.

Dulaglutide delivers significant reductions in glucose levels for youths with type 2 diabetes, report the AWARD-PEDS investigators.

The first phase 3 trial of an SGLT2 inhibitor in children and young people with type 2 diabetes shows that dapagliflozin significantly improves their glucose control – as long as they remember to take it.

The Patient Health Questionnaire-9, which screens for depressive symptoms, underestimates suicide risk in adolescents and young adults with type 1 diabetes when compared with a validated suicide-specific measure, research shows.

Young people with type 1 diabetes are at increased risk for hospitalization for acute complications at the time of transition from pediatric to adult care, say researchers.

Almost half of people diagnosed with type 2 diabetes in childhood develop retinopathy by their mid-20s, show TODAY2 data.